# Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC

> **NCT04759235** · — · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 118 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Magnetic resonance imaging (MRI)
- **DIAGNOSTIC_TEST:** 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT)
- **DIAGNOSTIC_TEST:** Blood and urine metabolic biomarker

## Key facts

- **NCT ID:** NCT04759235
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04759235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04759235, "Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04759235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*